SOFT 2004 Meeting Abstracts - Society of Forensic Toxicologists
SOFT 2004 Meeting Abstracts - Society of Forensic Toxicologists
SOFT 2004 Meeting Abstracts - Society of Forensic Toxicologists
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
P27 <br />
ANALYSIS OF POSTMORTEM BONEIBONE MARROW SPECIMENS FOR DRUGS OF<br />
IMPORTANCE IN FORENSIC TOXICOLOGY<br />
Kelly K. McGrath* and Amanda 1. Jenkins, Ph.D, The Office <strong>of</strong> the Cuyahoga County Coroner, 11001<br />
Cedar Avenue, Cleveland, OH 44106, U.S.A.<br />
To date, there is a paucity <strong>of</strong> literature published on the determination <strong>of</strong> drugs in bone and bone marrow.<br />
This type <strong>of</strong> research is important forensically because the extraction <strong>of</strong> bone specimens may be useful<br />
when traditional postmortem samples are not available for toxicological analysis. Postmortem bone<br />
samples, taken from the iliac crest in adults and vertebrae in infants, were extracted and analyzed for the<br />
presence <strong>of</strong> benzodiazepines and cocaine and metabolites. The purpose <strong>of</strong> this study was to correlate the<br />
concentration <strong>of</strong> drugs found in postmortem blood with the concentrations in boneibone marrow samples.<br />
The specimens were thoroughly cleaned by removing all traces <strong>of</strong> skeletal muscle and tissue and then<br />
rinsing with deionized water until the wash ran clear. Two grams <strong>of</strong> each bonelbone marrow sample was<br />
cut into slivers and soaked in 4 milliliters <strong>of</strong> methanol for sixteen hours (± 0.5 hours). Cocaine and<br />
metabolites were extracted from the methanol by liquid/liquid extraction followed by solid phase extraction<br />
(SPE), derivatization with MSTFA,· and analysis by GCIMS in single ion monitoring (SIM) mode.<br />
Benzodiazepines (BDP) were isolated from the methanol extract by liquid/liquid extraction and analyzed<br />
by GC/ECD.<br />
The concentration <strong>of</strong> drugs found in the bonelbone marrow samples was compared to postmortem blood<br />
toxicology results. Three <strong>of</strong> seven cases analyzed for cocaine and metabolites were positive. In one case,<br />
cocaine was quantitated at 120 nglg bone, cocaethylene 80 nglg bone, and ecgonine methyl ester (EME)<br />
was qualitatively positive. The heart blood results in this case were benzoylecgonine (BE) 332 ng/ml,<br />
cocaine 144nglml, cocaethylene 32 nglml, and EME qualitatively positive. In another case, BE was<br />
quantitated at 666 nglg bone and in the heart blood BE was 522 nglml. The third case had 48 nglg bone<br />
cocaethylene and EME was qualitatively positive. The heart blood in this case contained 211 ng/ml BE, 29<br />
nglml cocaine, and EME was qualitatively positive. The remaining four cases were negative for cocaine<br />
and metabolites in the boneibone marrow and the blood concentrations for BE and cocaine ranged from<br />
123 nglrnl-394 nglml and 24 ng/ml-29 nglml respectively. These positive cases demonstrate that cocaine<br />
and metabolites can be detected in bone, but the presence <strong>of</strong> specific analytes may differ from those present<br />
in the blood and the concentration <strong>of</strong> the analytes in boneibone marrow may be higher or lower than that in<br />
the blood. Therefore, these results should be interpreted cautiously.<br />
Six cases were examined for the presence <strong>of</strong>BDP. Ofthese six cases, four were positive for diazepam with <br />
values ranging from 0.60 ug/g bone-2.4 ug/g bone, four were positive for desmethyldiazepam (DMD) with <br />
. values ranging from 0.32 uglg bone-l.6 uglg bone, and one case was unsuitable for analysis. In the cases <br />
where diazepam was positive in the bonelbone marrow, the heart blood concentrations ranged from 0.13 <br />
mg/L-0.39 mg/L. DMD in the heart blood ranged from 0.10 mg/L-0.67 mg/L. In every case where <br />
diazepam and/orDMD were present in the heart blood, both were also recovered in the boneibone marrow. <br />
These results demonstrate that· bonelbone marrow specimens may be utilized as an alternative matrix for<br />
postmortem toxicological analysis where traditional matrices are not available. The preliminary data on<br />
cocaine and metabolites and BDP failed to show a linear correlation between boneibone marrow and blood<br />
drug concentrations. It appears that the likelihood <strong>of</strong> detecting a drug in boneibone marrow specimens<br />
depends on the type <strong>of</strong> drug being analyzed. Future investigation <strong>of</strong> other drug classes such as opiates,<br />
basic, and acidic/neutral drugs may provide additional information for the elucidation <strong>of</strong> correlation data<br />
between bonelbone marrow and blood specimens.<br />
KEYWORDS: Bone, Cocaine, Benzodiazepine<br />
Page 362